Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Roche patents anti-pY796-DDR1 antibodies

June 8, 2018

Secarna Pharmaceuticals patents novel anti-CD39 immunosuppression-reverting oligonucleotides

May 8, 2018

Bristol-Myers Squibb presents new TYK2 inhibitors

April 25, 2018

Afecta Pharmaceuticals patents novel hgh mobility group protein B1 inhibitors

April 25, 2018

Novel calpain inhibitors identified at Blade Therapeutics

April 23, 2018

Pliant Therapeutics patents new integrin alphavbeta1 antagonists

April 5, 2018

Genentech and Roche present new HsNIK inhibitors

March 22, 2018

Institut Pasteur de Montevideo and Universidad de la Republica describe new trolox derivatives

March 21, 2018

Lycera patents new Rho-associated protein kinase 1/2 inhibitors

March 19, 2018

New polynucleotides encoding semaphorin-6 synthesized at Kanazawa University

March 8, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...